文献速递糖尿病

人工胰腺进餐检测算法:青少年1型糖尿病随机对照试验

A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2020-12-04

该随机交叉试验在11名12-18岁、HbA1c≥7.5%且近6个月漏打胰岛素bolus的青少年1型糖尿病患者中,比较持续皮下胰岛素输注(CSII)、人工胰腺(AP)与带进餐检测算法的人工胰腺(AP+MDA)三种9小时干预(含带bolus早餐和不带bolus午餐)。AP+MDA检测进餐时间为40.0(四分位距40.0-57.5)min,较CSII降低午餐后4小时iAUC并减少血糖>10 mmol/L时间。

要点

  • AP+MDA可检测未提前告知的进餐并自动给予胰岛素bolus。
  • AP+MDA较CSII降低未告知午餐后4小时iAUC并减少高血糖时间。
  • AP+MDA与单独AP相比iAUC无显著差异,但高血糖时间更低。

核心结论

  • AP+MDA改善了未提前告知进餐后的血糖控制。

研究设计与样本

  • 随机交叉试验纳入11名12-18岁、HbA1c≥7.5%且近6个月至少漏打一次bolus的青少年1型糖尿病患者。
  • 比较CSII、AP与AP+MDA三种干预,每种干预9小时,含带bolus早餐和不带bolus午餐。

主要发现

  • AP+MDA进餐检测时间为40.0(四分位距40.0-57.5)min。
  • AP+MDA较CSII将午餐后4小时iAUC从24.1 ± 9.5降至15.4 ± 8.0 h·mmol/L(P = 0.03)。
  • AP+MDA与AP的iAUC无差异(19.6 ± 10.4 h·mmol/L,P = 0.21),AP与CSII亦无差异(P = 0.33)。
  • AP+MDA的血糖>10 mmol/L时间(58.0 ± 26.6%)低于CSII(79.6 ± 27.5%,P = 0.02)和AP(74.2 ± 20.6%,P = 0.047)。

临床怎么用

  • 对于常漏打餐时bolus的青少年1型糖尿病患者,AP+MDA可能有助改善未告知进餐后的血糖控制。

局限性

  • 样本量仅11名青少年,干预时长为9小时,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We developed a meal detection algorithm for the artificial pancreas (AP+MDA) that detects unannounced meals and delivers automatic insulin boluses. RESEARCH DESIGN AND METHODS: We conducted a randomized crossover trial in 11 adolescents aged 12-18 years with HbA1c ≥7.5% who missed one or more boluses in the past 6 months. We compared 1) continuous subcutaneous insulin infusion (CSII), 2) artificial pancreas (AP), and 3) AP+MDA. Participants underwent three 9-h interventions involving breakfast with a bolus and lunch without a bolus. RESULTS: In AP+MDA, the meal detection time was 40.0 (interquartile range 40.0-57.5) min. Compared with CSII, AP+MDA decreased the 4-h postlunch incremental area under the curve (iAUC) from 24.1 ± 9.5 to 15.4 ± 8.0 h ⋅ mmol/L (P = 0.03). iAUC did not differ between AP+MDA and AP (19.6 ± 10.4 h ⋅ mmol/L, P = 0.21) or between AP and CSII (P = 0.33). The AP+MDA reduced time >10 mmol/L (58.0 ± 26.6%) compared with CSII (79.6 ± 27.5%, P = 0.02) and AP (74.2 ± 20.6%, P = 0.047). CONCLUSIONS: The AP+MDA improved glucose control after an unannounced meal.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Palisaitis E, El Fathi A, von Oettingen JE, et al. A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes. Diabetes Care. 2020. PMID: 33277302. doi:10.2337/dc20-1232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。